- Home
- BTAI vs PGHL Comparison
BTAI vs PGHL Comparison
Compare BTAI & PGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- PGHL
- Stock Information
- Founded
- BTAI 2017
- PGHL 2018
- Country
- BTAI United States
- PGHL Hong Kong
- Employees
- BTAI N/A
- PGHL N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- PGHL
- Sector
- BTAI Health Care
- PGHL
- Exchange
- BTAI Nasdaq
- PGHL NYSE
- Market Cap
- BTAI 10.7M
- PGHL 12.0M
- IPO Year
- BTAI 2018
- PGHL 2024
- Fundamental
- Price
- BTAI $1.46
- PGHL $0.81
- Analyst Decision
- BTAI Buy
- PGHL
- Analyst Count
- BTAI 5
- PGHL 0
- Target Price
- BTAI $42.60
- PGHL N/A
- AVG Volume (30 Days)
- BTAI 97.3K
- PGHL 1.1M
- Earning Date
- BTAI 05-12-2025
- PGHL 05-27-2025
- Dividend Yield
- BTAI N/A
- PGHL N/A
- EPS Growth
- BTAI N/A
- PGHL N/A
- EPS
- BTAI N/A
- PGHL N/A
- Revenue
- BTAI $1,852,000.00
- PGHL $17,166,534.00
- Revenue This Year
- BTAI $41.00
- PGHL N/A
- Revenue Next Year
- BTAI $197.21
- PGHL N/A
- P/E Ratio
- BTAI N/A
- PGHL $25.15
- Revenue Growth
- BTAI 5.47
- PGHL 56.11
- 52 Week Low
- BTAI $1.29
- PGHL $0.37
- 52 Week High
- BTAI $42.08
- PGHL $107.36
- Technical
- Relative Strength Index (RSI)
- BTAI 37.90
- PGHL N/A
- Support Level
- BTAI $1.34
- PGHL N/A
- Resistance Level
- BTAI $1.64
- PGHL N/A
- Average True Range (ATR)
- BTAI 0.15
- PGHL 0.00
- MACD
- BTAI -0.01
- PGHL 0.00
- Stochastic Oscillator
- BTAI 16.56
- PGHL 0.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.